Showing results (101-110 of 293) with videos related to

Sort By:
Pageof 30
Carcinogenesis|August 13, 2016
Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillanceXiang Shu, Yuanqing Ye, Jian Gu, et al.
Cancer Research|September 3, 2004
Growth and survival mechanisms associated with perineural invasion in prostate cancerGustavo E Ayala, Hong Dai, Michael Ittmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 6, 2004
Combined laser capture microdissection and serial analysis of gene expression from human tissue samplesJeong Hee Cho-Vega, Patricia Troncoso, Kim-Anh Do, et al.
The Journal of Urology|July 29, 2020
The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active SurveillanceJustin R Gregg, Devaki Shilpa Surasi, Alexandria Childs, et al.
Cancer|October 10, 2006
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinomaNizar M Tannir, Lorenzo Cohen, Xuemei Wang, et al.
Clinical Genitourinary Cancer|February 15, 2008
Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapyGuru Sonpavde, Ana Aparicio, Israel Guttierez, et al.
Revista Espanola De Enfermedades Digestivas|February 24, 2022
Mesalazine induced interstitial pneumonitis in the COVID eraAna Aparicio Serrano, Elma Gallego Jiménez, Javier Castro Rodríguez, et al.
The Oncologist|November 18, 2024
Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancerEfstratios Koutroumpakis, Neha Venkatesh, Ana Aparicio, et al.
Human Gene Therapy|March 5, 2003
Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancerTakefumi Satoh, Terry L Timme, Takashi Saika, et al.
Current Medical Research and Opinion|July 27, 2007
The VIOXX in Prostate Cancer Prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groupsJanet van Adelsberg, Peter Gann, Amy T Ko, et al.
Pageof 30